16:20:45 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-13 Bokslutskommuniké 2024
2024-11-07 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-15 X-dag ordinarie utdelning ACARIX 0.00 SEK
2024-05-14 Årsstämma 2024
2024-05-14 Kvartalsrapport 2024-Q1
2024-02-21 Extra Bolagsstämma 2024
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-09-28 Extra Bolagsstämma 2023
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-12 X-dag ordinarie utdelning ACARIX 0.00 SEK
2023-05-11 Kvartalsrapport 2023-Q1
2023-05-11 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-11-16 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-12 X-dag ordinarie utdelning ACARIX 0.00 SEK
2022-05-11 Kvartalsrapport 2022-Q1
2022-05-11 Årsstämma 2022
2022-02-17 Bokslutskommuniké 2021
2021-11-23 Extra Bolagsstämma 2021
2021-11-11 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-12 X-dag ordinarie utdelning ACARIX 0.00 SEK
2021-05-11 Årsstämma 2021
2021-05-11 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-08-11 Extra Bolagsstämma 2020
2020-05-15 X-dag ordinarie utdelning ACARIX 0.00 SEK
2020-05-14 Kvartalsrapport 2020-Q1
2020-05-14 Årsstämma 2020
2020-02-20 Bokslutskommuniké 2019
2019-11-14 Kvartalsrapport 2019-Q3
2019-08-21 Kvartalsrapport 2019-Q2
2019-08-16 Extra Bolagsstämma 2019
2019-05-17 X-dag ordinarie utdelning ACARIX 0.00 SEK
2019-05-16 Årsstämma 2019
2019-05-16 Kvartalsrapport 2019-Q1
2019-02-20 Bokslutskommuniké 2018
2018-11-14 Kvartalsrapport 2018-Q3
2018-08-21 Kvartalsrapport 2018-Q2
2018-05-24 X-dag ordinarie utdelning ACARIX 0.00 SEK
2018-05-23 Årsstämma 2018
2018-05-23 Kvartalsrapport 2018-Q1
2018-02-26 Bokslutskommuniké 2017
2017-11-14 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-05-26 X-dag ordinarie utdelning ACARIX 0.00 SEK
2017-05-24 Årsstämma 2017
2017-05-24 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Acarix är ett diagnostikbolag. Bolaget har utvecklat en teknologi som möjliggör identifiering av kranskärlssjukdomar. Bolagets produkt är ett icke-invasivt test som sätts med en lapp på patienten för att analysera ljud från hjärtat. Idag innehas verksamhet främst inom den nordiska marknaden. Bolaget grundades under 2009 som en avknoppning från Coloplast. Huvudkontoret ligger i Malmö.
2023-09-27 09:45:00

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces expanded utilization of the CADScor® System into the first clinic for Osteopathic Medicine in the United States. The initial order from Legacy Medical LLC, located in the state of Georgia, is another key milestone in the company's ongoing commercialization efforts in the US market.

Osteopathic medicine is a "whole person" approach to medicine - treating the entire person rather than just the symptoms. In the US there are more than 186,000 Doctors of Osteopathic Medicine ("DO”) and medical students. The majority of DOs are family-oriented primary care physicians with a strong focus on preventive health.

"Preventative cardiology is a priority in our practice," Dr. Colette Bullock, DO, Owner/CEO of Legacy Medical LLC, emphasized. " As a Doctor of Osteopathic Medicine, I take a holistic approach to patient care, utilizing a methodology that addresses the needs of the whole person, incorporating family history, lifestyle factors, and diagnostic and lab testing results. This allows me to tailor a personalized treatment strategy to minimize the risks of cardiovascular disease for each of my patients. I look forward to incorporating the CADScor System into my diagnostic workflow, offering a fast and reliable risk stratification tool for patients with symptoms and suspicion of coronary artery disease. Within 10 minutes, I can confidently determine if I can rule out significant coronary artery disease during a single visit, which helps me decide the next steps for each patient."

"The adoption of the CADScor System into osteopathic clinics, such as Legacy Medical LLC, confirms its value in early rapid cardiac diagnostics and a large new market segment”, stated Helen Ljungdahl Round, Acarix President & CEO. “We are very interested in following Dr. Bullock and her commitment to both preventive strategies for maintaining good health and scientifically proven approaches for restoring health effectively." 

About Legacy Medical

Legacy Medical was created to address the needs of the whole person. Our vision is proactive. It offers the best preventive strategies to maintain good health, as well as the best scientifically proven strategies to restore health. Our goal is to find the root causes of ailments, not to mask their symptoms temporarily. Proven, minimally disruptive therapies are always considered first, while always utilizing standard conventional care when necessary. For more information, please visit https://legacymedllc.com/about/